Managing the gastrointestinal side effects of GLP-1 receptor agonists in obesity: recommendations for clinical practice
暂无分享,去创建一个
I. Lingvay | S. Wharton | D. Dicker | Ofri Mosenzon | D. Rubino | S. Pedersen | M. Davies
暂无分享,去创建一个
I. Lingvay | S. Wharton | D. Dicker | Ofri Mosenzon | D. Rubino | S. Pedersen | M. Davies